1. Summary Information

 

 

Country

India

Company Name

PREMIER NUTRACEUTICALS PRIVATE LIMITED

Principal Name 1

Mr. Arvind Shrinivasan Iyer

Status

Moderate

Principal Name 2

Mr. Priyamvada Arvind Iyer

 

 

Registration #

11-139209

Street Address

271, Tower ‘A’ Kalpataru Towers, Off. Akurli Road, Opposite ESIS Hospital, Kandivali (east), Mumbai – 400101, Maharashtra, India

Established Date

18.02.2003

SIC Code

--

Telephone#

91-22-30845901

Business Style 1

Manufacturer

Fax #

Not Available

Business Style 2

--

Homepage

www.pnpl.co.in

Product Name 1

Pharmaceutical formulation,

# of employees

Not Available

Product Name 2

Tablets

Paid up capital

Rs.41,400,000/-

Product Name 3

Syrups

Shareholders

Directors or relatives of Directors – 100%

Banking

Bank of India

Public Limited Corp.

No

Business Period

9 Years

IPO

No

International Ins.

-

Public Enterprise

No

Rating

B (30)

Related Company

Relation

Country

Company Name

CEO

--

--

--

--

Note

-

 

2. Summary Financial Statement

Balance Sheet as of

31.03.2011

(Unit: Indian Rs.)

Assets

Liabilities

Current Assets

76,015,000

Current Liabilities

54,824,000

Inventories

18,965,000

Long-term Liabilities

68,995,000 

Fixed Assets

74,361,000

Other Liabilities

-

Deferred Assets

--

Total Liabilities

 123,819,000

Invest& other Assets

9,000

Retained Earnings

4,131,000

 

 

Net Worth

45,531,000

Total Assets

169,350,000

Total Liab. & Equity

169,350,000

 Total Assets

(Previous Year)

106,763,000

 

 

P/L Statement as of

31.03.2011

(Unit: Indian Rs.)

Sales

207,331,000

Net Profit

39,875,000

Sales(Previous yr)

123,020,000

Net Profit(Prev.yr)

36,935,000

 

 

MIRA INFORM REPORT

 

 

Report Date :

26.04.2012

 

IDENTIFICATION DETAILS

 

Name :

PREMIER NUTRACEUTICALS PRIVATE LIMITED

 

 

Registered Office :

271, Tower ‘A’ Kalpataru Towers, Off. Akurli Road, opposite ESIS Hospital, Kandivali (east), Mumbai – 400101, Maharashtra

 

 

Country :

India

 

 

Financials (as on) :

31.09.2011

 

 

Date of Incorporation :

18.02.2003

 

 

Com. Reg. No.:

11-139209

 

 

Capital Investment / Paid-up Capital :

Rs.41.400 Millions

 

 

CIN No.:

[Company Identification No.]

U24230MH2003PTC139209

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturer of pharmaceutical formulation, tablets, syrups, ointments, calcium tablets b-12 etc.

 

 

No. of Employees :

Not Available

 

 

RATING & COMMENTS

 

MIRA’s Rating :

B (30)

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Maximum Credit Limit :

USD 180000

 

 

Status :

Moderate

 

 

Payment Behaviour :

Slow

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having moderate track. Profitability appears to be low. Trade relations are reported as fair. Business is active. Payments are reported to be slow.

 

The company can be considered for business dealings with some cautions. 

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – September 30, 2011

 

Country Name

Previous Rating

(30.06.2011)

Current Rating

(30.09.2011)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

 

 

 

 

 

           

 

 

 

 

 

LOCATIONS

 

Registered Office :

271, Tower ‘A’ Kalpataru Towers, Off. Akurli Road, opposite ESIS Hospital, Kandivali (east), Mumbai – 400101, Maharashtra, India

Tel. No.:

91-22-30845901

Fax No.:

Not Available

E-Mail :

glen.office@gmail.com

Website :

www.pnpl.co.in

 

 

Corporate Office :

714/715 MIDS, Sahar Plaza, Andheri-Kurla Road, Andheri (East), Mumbai – 400059, Maharashtra, India

Tel. No.:

91-22-30845900 / 30823309

Fax No.:

91-22-28268229

E-Mail :

info@pnpl.co.in

 

 

Factory  :

Plot No.33, Pharma City, Selaqui Industrial Estate, Selaqui, Dehradun - 248197, Uttarakhand, India 

E-Mail :

infodoon@pnpl.co.in

 

 

Zonal Office :

Shreyas Siddhi Apartments, Plot No. 180, B-17B, Bajaja Nagar, Above Advocate ‘Ajay Mohgaokar Office’ Nagpur – 440101, Maharashtra, India 

E-Mail :

nagpur@pnpl.co.in

 

 

DIRECTORS

 

As on 30.09.2011

 

Name :

Mr. Arvind Shrinivasan Iyer

Designation :

Managing Director

Address :

Flat No.131, C-Wing, Kalpataru, J.V. Link Road, Andheri (East), Mumbai – 400093, Maharashtra, India

Date of Birth/Age :

27.03.1962

Date of Appointment :

18.02.2003

DIN No.:

01375173

Other Directorship

S.No.

CIN

Name of the Company

Current designation of the director

Date of appointment at current designation

Original date of appointment

Date of cessation

Company Status

Defaulting status

1

U24230MH2003PTC139209

PREMIER NUTRACEUTICALS PRIVATE LIMITED

Managing director

18/02/2003

18/02/2003

-

Active

NO

2

U85100MH2007PTC176361

PREMIER HEALTHCARE MARKETING PRIVATE LIMITED

Director

30/09/2008

12/4/2008

-

Active

NO

3

U24233MH2011PTC219825

PREMIER NUTRICARE PRIVATE LIMITED

Director

15/07/2011

15/07/2011

-

Active

NO

 

 

Name :

Mr. Priyamvada Arvind Iyer

Designation :

Director

Address :

Flat No.131, C-Wing, Kalpataru, J.V. Link Road, Andheri (East), Mumbai – 400093, Maharashtra, India

Date of Birth/Age :

14.01.1965

Date of Appointment :

18.02.2003

DIN No.:

01377052

Other Directorship

S.No.

CIN

Name of the Company

Current designation of the director

Date of appointment at current designation

Original date of appointment

Date of cessation

Company Status

Defaulting status

1

U24230MH2003PTC139209

PREMIER NUTRACEUTICALS PRIVATE LIMITED

Director

18/02/2003

18/02/2003

-

Active

NO

2

U85100MH2007PTC176361

PREMIER HEALTHCARE MARKETING PRIVATE LIMITED

Director

30/09/2008

12/4/2008

-

Active

NO

3

U24233MH2011PTC219825

PREMIER NUTRICARE PRIVATE LIMITED

Director

15/07/2011

15/07/2011

-

Active

NO

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on 30.09.2011

 

Equity Share

Names of Shareholders

 

No. of Shares

Arvind Shrinivasan Iyer

 

2690000

Priyamvada Arvind Iyer

 

310000

Total

 

3000000

 

Preference Shares

Names of Shareholders

 

No. of Shares

Girdhari R. Tulsani

 

570000

Ekta Girdhari Tulsani

 

570000

Total

 

1140000

 

As on 30.09.2011

Equity Share Break up (Percentage of Total Equity)

 

Category

Percentage

Directors or relatives of Directors

100.00

Total

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer of pharmaceutical formulation, tablets, syrups, ointments, calcium tablets b-12 etc.

 

 

Products :

  • Coral Calcium Tablets
  • Coral Calcium XS Tablets
  • Irrochel Tab & Syrup
  • 2B12 Capsules
  • Manna Protein Powder
  • Prorac Capsules
  • Prorac Skin Cream

 

 

 

 

GENERAL INFORMATION

 

No. of Employees :

Not Available

 

 

Bankers :

Bank of India, Andheri (West) Branch,M. D. I. Building, Ground Floor, 28, S. V. Road, Andheri (West),, Mumbai - 400058, Maharashtra, India

 

 

Facilities :

(Rs. In Millions)

Secured Loan

As on

31.03.2011

As on

31.03.2010

Secured Loan

48.995

26.135

Total

48.995

26.135

 

 

 

Unsecured Loan

As on

31.03.2011

As on

31.03.2010

Unsecured Loan

20.000

0.000

Total

20.000

0.000

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

Christopher D;Souza and Associates

Chartered Accountants

Address :

2, Witsend, 70-D, Hill Road, Bandra (West), Mumbai – 400050, Maharashtra, India 

Tel. No.:

91-22-26430078 / 26436292 / 64204401

Mobile No.:

91-9833597056

Fax No.:

91-22-26402923

Website :

www.chris-associates.com

PAN.:

AAEFC3349L

 

 

 

CAPITAL STRUCTURE

 

As on 31.03.2011

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

7500000

Equity Shares

Rs.10/- each

Rs.75.000 Millions

2500000

Preference Shares

Rs.10/- each

Rs.25.000 Millions

 

Total

 

Rs.100.000 Millions

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

3000000

Equity Shares

Rs.10/- each

Rs.30.000 Millions

1140000

Preference Shares

Rs.10/- each

Rs.11.400 Millions

 

Total

 

Rs.41.400 Millions

 

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2011

31.03.2010

31.03.2009

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

41.400

41.400

30.000

2] Share Application Money

0.000

0.000

0.000

3] Reserves & Surplus

4.131

0.020

0.000

4] (Accumulated Losses)

0.000

0.000

0.000

NETWORTH

45.531

41.420

30.000

LOAN FUNDS

 

 

 

1] Secured Loans

48.995

26.135

15.290

2] Unsecured Loans

20.000

0.000

11.431

TOTAL BORROWING

68.995

26.135

26.721

DEFERRED TAX LIABILITIES

0.000

0.000

0.000

 

 

 

 

TOTAL

114.526

67.555

56.721

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

74.361

30.578

30.425

Capital work-in-progress

0.000

17.743

0.000

 

 

 

 

INVESTMENT

0.000

0.000

0.000

DEFERREX TAX ASSETS

0.000

0.000

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

18.965

22.754

8.460

 

Sundry Debtors

46.139

10.581

12.083

 

Cash & Bank Balances

17.750

12.664

12.546

 

Other Current Assets

0.000

0.000

0.000

 

Loans & Advances

12.126

12.430

6.277

Total Current Assets

94.980

58.429

39.366

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Sundry Creditors

39.134

31.258

14.502

 

Other Current Liabilities

 

 

 

 

Provisions

15.690

7.951

2.918

Total Current Liabilities

54.824

39.208

17.420

Net Current Assets

40.156

19.221

21.946

 

 

 

 

MISCELLANEOUS EXPENSES

0.009

0.013

0.017

Others (Reserves and Surplus)

0.000

0.000

4.333

 

 

 

 

TOTAL

114.526

67.555

56.721

 


PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2011

31.03.2010

31.03.2009

 

SALES

 

 

 

 

 

Income

207.331

123.020

77.275

 

 

Other Income

1.045

1.864

0.871

 

 

TOTAL                                     (A)

208.376

124.884

78.146

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Inclining Increase /  (Decrease) in Stock of Finished Goods Office Expenses

(9.545)

11.616

0.282

 

 

Other Expenses

146.582

75.121

51.842

 

 

TOTAL                                     (B)

147.037

86.737

52.130

 

 

 

 

 

Less

PROFIT BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)      (C)

61.339

38.147

26.016

 

 

 

 

 

Less

FINANCIAL EXPENSES                         (D)

5.773

1.971

4.027

 

 

 

 

 

 

PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                                       (E)

55.566

36.176

21.989

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

4.677

3.641

3.750

 

 

 

 

 

 

PROFIT BEFORE TAX (E-F)                               (G)

50.889

32.535

18.239

 

 

 

 

 

Less

TAX                                                                  (H)

11.014

5.600

3.290

 

 

 

 

 

 

PROFIT AFTER TAX (G-H)                                (I)

39.875

26.935

14.949

 

 

 

 

 

Add

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

0.020

(4.333)

(19.282)

 

 

 

 

 

Less

APPROPRIATIONS

 

 

 

 

 

Dividend

30.768

19.500

0.000

 

 

Tax on Dividend

4.996

3.082

0.000

 

BALANCE CARRIED TO THE B/S

4.131

0.020

(4.333)

 

 

 

 

 

 

Earnings Per Share (Rs.)

9.63

--

--

 

 

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2011

31.03.2010

31.03.2009

PAT / Total Income

(%)

19.14

21.57

19.13

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

24.54

26.45

23.60

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

30.05

36.55

26.13

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

1.12

0.79

0.61

 

 

 

 

 

Debt Equity Ratio

(Total Liability/Networth)

 

2.72

1.58

1.47

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.73

1.49

2.26

 

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Check List by Info Agents

Available in Report (Yes / No)

1) Year of Establishment

Yes

2) Locality of the firm

Yes

3) Constitutions of the firm

Yes

4) Premises details

No

5) Type of Business

Yes

6) Line of Business•

Yes

7) Promoter’s background

Yes

8) No. of employees

No

9) Name of person contacted

No

10) Designation of contact person

No

11) Turnover of firm for last two years

Yes

12) Profitability for last three years

Yes

13) Reasons for variation <> 20%

--

14) Estimation for coming financial year

No

15) Capital in the business

Yes

16) Details of sister concerns

No

17) Major suppliers

No

18) Major customers

No

19) Payments terms

No

20) Export / Import details (if applicable)

No

21) Market information

--

22) Litigations that the firm / promoter

--

23) Banking Details

Yes

24) Banking facility details

Yes

25) Conduct of the banking account

--

26) Buyer visit details

--

27) Financials, if provided

Yes

28) Incorporation details, if applicable

Yes

29) Last accounts filed at ROC

Yes

30) Major Shareholders, if available

Yes

 

 

Note:

The registered office of the company has been shifted from 2-Witesnd 70-D, Hill Road, Bandra (West) Mumbai – 400050, Maharashtra, India to present address w.e.f. 27.01.2012

 

 

OPERATIONAL REVIEW

The Company has achieved turnover of Rs.208.375 Millions during the year as compared to turnover of Rs.124.884 Millions during previous year. There is profit before depreciation, interest and tax of Rs.61.339 Millions (Previous year Profit Rs.38.148 Millions). After charging depreciation of Rs.4.677 Millions (Previous year Rs.3.642 Millions) and interest of Rs.5.773 Millions (Previous year Rs.1.970 Millions), there is profit before tax of Rs.50.889 Millions (Previous year Profit of Rs.32.535 Millions). There is profit after tax of Rs.39.875 Millions (Previous year Profit of Rs.22.602 Millions).

 

 

FUTURE PLANS AND OUTLOOK:

The company is expanding its activities by installing additional machineries at newly constructed factory building, some of the machinery already installed during the year, adjoining to the existing factory premises at plot No. 33, Pharma City, Selaqui Dehradun, Uttranchal. The production capacity will increase by 100%. The demand for the products of the company is expanding and export opportunities are also increasing, the company is expecting growth of the company at accelerated rate.

 

FINANCE

The company during the year enjoyed working capital loans, term loan and non-fund based limit, from the Bank of India, Andheri (West), Branch

 

 

 

Bankers Charges Report as per Registry

Corporate identity number of the company

U24230MH2003PTC139209

Name of the company

PREMIER NUTRACEUTICALS PRIVATE LIMITED

Address of the registered office or of the principal place of  business in India of the company

271, Tower ‘A’ Kalpataru Towers, Off. Akurli Road, opposite ESIS Hospital, Kandivali (east), Mumbai – 400101, Maharashtra, India

pnplacc@gmail.com

This form is for

Modification of charge

Charge identification (ID) number of the charge to be modified

80033077

Type of charge

  • Book debts
  • Movable property (not being pledge)

Particular of charge holder

Bank of India, Andheri (West) Branch, M. D. I. Building, Ground Floor, 28, S. V. Road, Andheri (West),, Mumbai - 400058, Maharashtra, India

arun.govil@gmail.com

Nature of instrument creating charge

Supplemental Deed of Hypothecation

Date of instrument Creating the charge

28.05.2010

Amount secured by the charge

Rs.75.107 Millions

Brief of the principal terms an conditions and extent and operation of the charge

Rate of Interest

CC (Stocks and BD) and TL- Interest@12.00% p. a. (Presently PLR) shall be charged at Monthly rests.

LC as per extent HO Guidelines

 

Terms of Repayment

CC (Stocks and Book Debts)- On Demand

Term Loan as per extent guidelines

 

Margin

Term Loan I and II - 50%

Term Loan Fresh-20%

Cash Credit-(Stocks)-20%

Cash Credit-(Book Debts)-30%

L/C ( DP/DA-180 days)-10% DP, 25% DA

 

Extent and Operation of the charge

Exclusive charge by way of hypothecation of all movable properties of the company

 

Others

Limits enhanced from Rs.43.554 Millions to Rs.75.107 Millions

Short particulars of the property or asset(s) charged (including complete address and location of the property)

Hypothecation of Stocks, Book debts, Plant and Machinery both present and future on the Company.

Date of instrument modifying the charge

02.05.2009

Particulars of the present modification

By Present modi. Hypothecation of Stocks, Book Debts, and plant and machinery has now increased from  Rs.43.554 Millions to Rs.75.107 Millions detailed as under

1) Term Loan-I  Rs.6.100 Millions

2) TL-II  Rs.1.952 Millions

3) TL-III (Fresh) Rs.12.055 Millions

4) CC (Stock)  Rs.17.500 Millions

5) CC (BD) Rs.25.000 Millions, Max.4 and 5 Rs.40.000 Millions

6) L/C  Rs.15.000 Millions

   Aggregate Total Rs.75.107 Millions

 

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                  None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.52.49

UK Pound

1

Rs.84.66

Euro

1

Rs.69.25

 

 

INFORMATION DETAILS

 

Report Prepared by :

NTH

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

4

PAID-UP CAPITAL

1~10

4

OPERATING SCALE

1~10

3

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

3

--PROFITABILIRY

1~10

3

--LIQUIDITY

1~10

4

--LEVERAGE

1~10

3

--RESERVES

1~10

3

--CREDIT LINES

1~10

3

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

NO

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

NO

TOTAL

 

30

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

-

NB

                                       New Business

-

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.